{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:56:59Z","timestamp":1768276619096,"version":"3.49.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T00:00:00Z","timestamp":1281657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0012144","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T20:45:50Z","timestamp":1281732350000},"page":"e12144","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine"],"prefix":"10.1371","volume":"5","author":[{"given":"Richarda M.","family":"de Voer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Mollema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutger M.","family":"Schepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine C.","family":"de Greeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter G. M.","family":"van Gageldonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth A. M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy A. M.","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona R. M.","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,8,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","article-title":"Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands.","volume":"25","author":"SC de Greeff","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"ref2","article-title":"Universal vaccination against meningococcal serogroup C and pneumococcal disease.","year":"2002"},{"key":"ref3","article-title":"\u2018da's goed gedaan? Woordverslag van de landelijke vaccinatiecampagne meningokokken C.","author":"SE Neppelenbroek","year":"2002"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.","volume":"364","author":"CL Trotter","year":"2004","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.","volume":"23","author":"A Larrauri","year":"2005","journal-title":"Vaccine"},{"key":"ref6","first-page":"E060302","article-title":"Introduction of pneumococcal conjugate vaccine to the UK childhood immunisation programme, and changes to the meningitis C and Hib schedules.","volume":"11","author":"C Cameron","year":"2006","journal-title":"Euro.Surveill"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.","volume":"183","author":"P Richmond","year":"2001","journal-title":"J Infect. Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.inf.0000151029.58752.27","article-title":"Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.","volume":"24","author":"MD Snape","year":"2005","journal-title":"Pediatr.Infect.Dis J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study.","volume":"7659","author":"MD Snape","year":"2008","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/CVI.00279-08","article-title":"Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era. Clin","volume":"15","author":"CL Trotter","year":"2008","journal-title":"Vaccine Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.","volume":"69","author":"R Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection--serum bactericidal antibody activity.","volume":"23","author":"R Borrow","year":"2005","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2006.09.087","article-title":"Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.","volume":"25","author":"JL Backhouse","year":"2007","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1016\/j.vaccine.2007.07.019","article-title":"Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.","volume":"25","author":"M Ceyhan","year":"2007","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S0950268898001587","article-title":"Immunosurveillance and the evaluation of national immunization programmes: a population-based approach.","volume":"121","author":"HE de Melker","year":"1998","journal-title":"Epidemiol.Infect"},{"key":"ref16","first-page":"301","article-title":"Second national serum bank for population-based seroprevalence studies in the Netherlands.","volume":"67","author":"FR van der Klis","year":"2009","journal-title":"Neth J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/CVI.00364-08","article-title":"Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay.","volume":"16","author":"RM de Voer","year":"2009","journal-title":"Clin.Vaccine Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.","volume":"335","author":"PG van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.","volume":"4","author":"SE Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.","volume":"177","author":"D Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1128\/IAI.60.11.4838-4847.1992","article-title":"Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid.","volume":"60","author":"RG Bredius","year":"1992","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1016\/j.vaccine.2009.05.047","article-title":"Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.","volume":"33","author":"II Sakou","year":"2009","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CVI.00420-08","article-title":"Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.","volume":"16","author":"J Southern","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/INF.0b013e3181b9a831","article-title":"A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months.","volume":"29","author":"J D\u00edez-Domingo","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.","volume":"17","author":"R Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies.","volume":"129","author":"I Goldschneider","year":"1969","journal-title":"J Exp.Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.021908.132607","article-title":"Human marginal zone B cells.","volume":"27","author":"JC Weill","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1128\/IAI.70.12.6583-6588.2002","article-title":"Development of interleukin-12-producing capacity throughout childhood.","volume":"70","author":"JW Upham","year":"2002","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4049\/jimmunol.176.1.165","article-title":"Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival.","volume":"176","author":"M Pihlgren","year":"2006","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/CVI.00047-06","article-title":"Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine.","volume":"13","author":"B Feiring","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.","volume":"17","author":"H Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.","volume":"180","author":"RG Blanchard","year":"2008","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1086\/599347","article-title":"Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.","volume":"49","author":"RM de Voer","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"F43","DOI":"10.1136\/fn.74.1.F43","article-title":"Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy.","volume":"74","author":"TJ O'Dempsey","year":"1996","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity.","volume":"129","author":"I Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.","volume":"359","author":"MC Maiden","year":"2002","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/IAI.6.5.651-656.1972","article-title":"Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3.","volume":"6","author":"JB Robbins","year":"1972","journal-title":"Infect Immun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1128\/IAI.8.6.896-900.1973","article-title":"Polysaccharides of the genus Bacillus cross-reactive with the capsular polysaccharides of Diplococcus pneumoniae type 3, Haemophilus influenzae type b, and Neisseria meningitidis group A.","volume":"8","author":"RL Myerowitz","year":"1973","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/IAI.13.6.1654-1662.1976","article-title":"Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide.","volume":"13","author":"WF Vann","year":"1976","journal-title":"Infect Immun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.","volume":"43","author":"MD Snape","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1016\/j.vaccine.2009.09.082","article-title":"Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults.","volume":"27","author":"RM de Voer","year":"2009","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.","volume":"179","author":"P Richmond","year":"1999","journal-title":"J Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0012144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T12:34:03Z","timestamp":1591792443000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0012144"}},"subtitle":[],"editor":[{"given":"Vasee","family":"Moorthy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,13]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0012144","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,13]]}}}